Treatment of lung cancer with a parp inhibitor in combination with a growth factor inhibitor
作者： Valeria S. Ossovskaya , Charles Bradley , Barry M. Sherman
DOI:
关键词:
摘要: In one aspect, the present invention provides a method of treating lung cancer, comprising administering to subject at least PARP inhibitor in combination with growth factor inhibitor. another non-small cell cancer
lens.org 参考文章(20)
Charles J. Dimitroff, Wayne Klohs, Amarnath Sharma, Paula Pera, Denise Driscoll, Jean Veith, Randall Steinkampf, Mel Schroeder, Sylvester Klutchko, Adam Sumlin, Barbara Henderson, Thomas J. Dougherty, Ralph J. Bernacki, Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy. Investigational New Drugs. ,vol. 17, pp. 121- 135 ,(1999) , 10.1023/A:1006367032156
Jerome Mendeleyev, Eva Kirsten, Alaeddin Hakam, Kalman G. Buki, Ernest Kun, Potential chemotherapeutic activity of 4-iodo-3-nitrobenzamide: Metabolic reduction to the 3-nitroso derivative and induction of cell death in tumor cells in culture Biochemical Pharmacology. ,vol. 50, pp. 705- 714 ,(1995) , 10.1016/0006-2952(95)00189-7
Noah S Scheinfeld, Barry Sloan, Pazopanib, a VEGF receptor tyrosine kinase inhibitor for cancer therapy. Current opinion in investigational drugs. ,vol. 9, pp. 1324- 1335 ,(2008)
Jerome Mendeleyev, Hassan Lemjabbar-Alaoui, Carol Basbaum, Ernest Kun Kun, Valeria Ossovskaya, Treatment of Cancer ,(2006)
Valeria S. Ossovskaya, Barry M. Sherman, Method of treating diseases with parp inhibitors ,(2007)
Dale L Ludwig, Fully human antibodies directed against the human insulin-like growth factor-1 receptor ,(2004)
Carsten Schultz-Fademrecht, Jesus Maria Ontoria Ontoria, Rita Scarpelli, Philip Jones, Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors ,(2008)
Yukihiko Nagase, Norio Suzuki, Hitoshi Yamaguchi, Cyclodextrin-containing pharmaceutical preparation ,(2001)
P. Perez-Pinera, T. Hernandez, O. García-Suárez, F. de Carlos, A. Germana, M. del Valle, A. Astudillo, J. A. Vega, The Trk tyrosine kinase inhibitor K252a regulates growth of lung adenocarcinomas Molecular and Cellular Biochemistry. ,vol. 295, pp. 19- 26 ,(2007) , 10.1007/S11010-006-9267-7
Martin Sebastian, Bernward Passlick, Hilke Friccius-Quecke, Michael Jäger, Horst Lindhofer, Frank Kanniess, Rainer Wiewrodt, Eckhard Thiel, Roland Buhl, Alexander Schmittel, Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study Cancer Immunology, Immunotherapy. ,vol. 56, pp. 1637- 1644 ,(2007) , 10.1007/S00262-007-0310-7